396 related articles for article (PubMed ID: 29126708)
21. Residual lesions in uterine specimens after loop electrosurgical excision procedure in patients with CIN.
Jing L; Dan W; Zhunan L; Ying X; Yi C
Arch Gynecol Obstet; 2018 Oct; 298(4):805-812. PubMed ID: 30167855
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
Ruano Y; Torrents M; Ferrer FJ
Eur J Gynaecol Oncol; 2015; 36(3):245-51. PubMed ID: 26189247
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for residual lesions after total hysterectomy in patients with high-grade cervical intraepithelial neoplasia.
Wang J; Wang C; Su T
BMC Womens Health; 2024 Jun; 24(1):369. PubMed ID: 38915002
[TBL] [Abstract][Full Text] [Related]
24. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
25. Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.
Onuki M; Matsumoto K; Sakurai M; Ochi H; Minaguchi T; Satoh T; Yoshikawa H
J Gynecol Oncol; 2016 Jan; 27(1):e3. PubMed ID: 26463429
[TBL] [Abstract][Full Text] [Related]
26. Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
Tropé A; Jonassen CM; Sjøborg KD; Nygård M; Dahl FA; Alfsen GC; Lie AK
Gynecol Oncol; 2011 Nov; 123(2):257-62. PubMed ID: 21839500
[TBL] [Abstract][Full Text] [Related]
27. [Importance of human papillomavirus (HPV) screening in the follow-up after CIN2-3 treatment].
Riethmuller D; Gabelle C; Ramanah R; Sautière JL; Prétet JL; Schaal JP; Kantelip B; Mougin C; Maillet R
J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):329-37. PubMed ID: 18424016
[TBL] [Abstract][Full Text] [Related]
28. Recurrent disease after treatment for cervical intraepithelial neoplasia-The importance of a flawless definition of residual disease and length of follow-up.
Bjørnerem MS; Sørbye SW; Skjeldestad FE
Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():44-49. PubMed ID: 32172024
[TBL] [Abstract][Full Text] [Related]
29. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
[TBL] [Abstract][Full Text] [Related]
31. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
32. Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia.
Ding T; Li L; Duan R; Chen Y; Yang B; Xi M
Int J Gynaecol Obstet; 2023 Feb; 160(2):538-547. PubMed ID: 35810389
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
Kang WD; Kim SM
Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
[TBL] [Abstract][Full Text] [Related]
34. Role of HPV in the Prediction of Persistence/Recurrence After Treatment for Cervical Precancer.
Kulkarni A; Covens A; Durand N; Ghorab Z; Gien LT; Osborne R; Vicus D; Kupets R
J Obstet Gynaecol Can; 2023 Oct; 45(10):102171. PubMed ID: 37343621
[TBL] [Abstract][Full Text] [Related]
35. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
[TBL] [Abstract][Full Text] [Related]
36. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
37. Prediction model for residual high-grade cervical intraepithelial lesions.
Yildirim Karaca S; Adiyeke M; Ince O; Ileri A; Vural T; Şahingöz Yildirim AG; Şenkaya AR; Bulut S; Kantarci S; Sanci M
Minerva Obstet Gynecol; 2023 Apr; 75(2):158-164. PubMed ID: 35107237
[TBL] [Abstract][Full Text] [Related]
38. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
[TBL] [Abstract][Full Text] [Related]
39. Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction.
Herfs M; Somja J; Howitt BE; Suarez-Carmona M; Kustermans G; Hubert P; Doyen J; Goffin F; Kridelka F; Crum CP; Delvenne P
Int J Cancer; 2015 Mar; 136(5):1043-52. PubMed ID: 24839092
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis.
Eriksen DO; Jensen PT; Schroll JB; Hammer A
Acta Obstet Gynecol Scand; 2022 Jun; 101(6):597-607. PubMed ID: 35470865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
